"We provide the highest level of medical and surgical eye care, enhancing the quality of our patients’ lives providing you and your family with compassionate personal care, utilizing the latest technology to diagnose and treat your condition."

During the past decade, R and R Eye Research conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "R and R Eye Research" are "Dry Eye" (1 trials), "Ocular Hypertension" (1 trials) and "Open-Angle Glaucoma" (1 trials). Many other conditions were trialed in "R and R Eye Research" in a lesser frequency.

Most popular intervention types in "R and R Eye Research" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Omega 3 fatty acid" (1 trials), "Placebos" (1 trials), "bimatoprost 0.03%" (1 trials), "bimatoprost 10 µg generation 1" (1 trials) and "bimatoprost 10 µg generation 2" (1 trials). Other intervention names were less common.

The vast majority of trials in "R and R Eye Research" are 2 trials for "All" genders.

Currently, there are NaN active trials in "R and R Eye Research". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in R and R Eye Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in R and R Eye Research, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".